MoneyWorks4Me

Zim Laboratories informs about transcript of earnings conference call

15 Nov 2023 Evaluate
Zim Laboratories has informed that it enclosed the transcript of Earnings Conference call for Q2 & H1FY24 held on Thursday, 09th November, 2023. The same is available on the Website of the Company at: https://www.zimlab.in/investor-reports-earnings-call

The above information is a part of company’s filings submitted to BSE.

Zim Laboratories Share Price

125.55 -2.40 (-1.88%)
04-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1899.00
Dr. Reddys Labs. 1154.00
Cipla 1385.00
Lupin 2111.00
Zydus Lifesciences 1121.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: